Browse Data and Analysis

Access to the benefits of modern agricultural biotechnology in the Caribbean Basin remains stifled by the unfinished work of implementing a science-based, risk-management approach to regulate its use.

Over a dozen Caribbean countries are Parties to the Cartagena Protocol on Biosafety. With an aim toward meeting their obligations under this agreement, many have been working toward establishing their National Biosafety Frameworks for many years.

With international funding to develop and implement biosafety regulatory systems drying up in 2019, Caribbean biosafety regulatory efforts remain in idle mode. The region is seeking further funding from the United Nations Environmental Program/Global...

The Government of Senegal is reviewing and revising its new biosafety law which may include language for an expedited approval process for certain genetically engineered (GE) products.

Many Caribbean Community (CARICOM) Member States have undertaken efforts to comply with their obligations under the Cartagena Protocol on Biosafety (CPB) to the Convention on Biological Diversity....

Many Caribbean Community (CARICOM) Member States have engaged in efforts to comply with their obligations under the Cartagena Protocol on Biosafety (CPB) to the Convention on Biological Diversity....

The Biosafety Law, 2012 contains information on the biotechnology approval process in Burkina Faso for GE products developed domestically or by a third country.

Biotech regulations have been virtually non-existent in the Caribbean. However, that may change in the years ahead....

On July, 26, 2016, The President of Cote d’Ivoire announced the implementation of the national biosafety law adopted by the parliament on July 1, 2016.

Biotech regulations have been virtually non-existent in the Caribbean. However, that may change in the years ahead as 12 Caribbean Community (CARICOM) countries move forward with a United Nations...

Biotech regulation has been virtually non-existent in the Caribbean.

Since January 2014, the Burkinabe National Biosafety Agency (NBA) has been converting the status of the organization to a technical and scientific public institution (EPSET) for greater autonomy.